Literature DB >> 598413

Modification of the binding of sulphamidochlorobenzoic acid to human albumin by palmitic acid contamination of albumin.

R Zini, P D'Athis, J P Tillement.   

Abstract

Palmitic acid a common contaminant of albumin preparations, competitively inhibits the binding of sulphamidochlorobenzoicacid (SCBA) to human albumin thus decreasing its observed affinity. The effect of palmitic acid depends on its concentration, i.e. the purity and concentration of the albumin preparation used. The correct value for SCBA affinity was obtained by correcting the experimental data according to the palmitic acid concentration by use of a multiligand analysis method.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 598413     DOI： 10.1007/bf00562457

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


  11 in total

1.  THE COLORIMETRIC MICRO-DETERMINATION OF NON-ESTERIFIED FATTY ACIDS IN PLASMA.

Authors:  W G DUNCOMBE
Journal:  Clin Chim Acta       Date:  1964-02       Impact factor: 3.786

2.  The binding of L-tryptophan to serum albumins in the presence of non-esterified fatty acids.

Authors:  V J Cunningham; L Hay; H B Stoner
Journal:  Biochem J       Date:  1975-03       Impact factor: 3.857

3.  Thermodynamics of fatty acid anion displacement of warfarin and phenylbutazone from human albumin.

Authors:  E G Rippie
Journal:  Biochem Pharmacol       Date:  1976-05-15       Impact factor: 5.858

4.  Multi-random binding molecular interactions: a general kinetic model.

Authors:  G Vassent
Journal:  J Theor Biol       Date:  1974-04       Impact factor: 2.691

5.  Effects of fatty acids on the interaction of 1-anilino-8-naphthalenesulfonate with human plasma albumin.

Authors:  E C Santos; A A Spector
Journal:  Mol Pharmacol       Date:  1974-05       Impact factor: 4.436

6.  Binding of certain acidic drugs to human albumin: theoretical and practical estimation of fundamental parameters.

Authors:  J P Tillement; R Zini; P d' Athis; G Vassent
Journal:  Eur J Clin Pharmacol       Date:  1974-07-26       Impact factor: 2.953

7.  The effect of fatty acids on the binding of tryptophan to plasma protein.

Authors:  G Curzon; J Friedel; P J Knott
Journal:  Nature       Date:  1973-03-16       Impact factor: 49.962

8.  Long chain fatty acid binding to human plasma albumin.

Authors:  J D Ashbrook; A A Spector; E C Santos; J E Fletcher
Journal:  J Biol Chem       Date:  1975-03-25       Impact factor: 5.157

9.  The effect of various drugs on the binding of warfarin-14C to human albumin.

Authors:  H M Solomon; J J Schrogie
Journal:  Biochem Pharmacol       Date:  1967-07-07       Impact factor: 5.858

10.  Binding of four sulphonamides to human albumin.

Authors:  R Zini; P d'Athis; A Hoareau; J P Tillement
Journal:  Eur J Clin Pharmacol       Date:  1976-06-15       Impact factor: 2.953
View more
  3 in total

Review 1.  Diseases and drug protein binding.

Authors:  J P Tillement; F Lhoste; J F Giudicelli
Journal:  Clin Pharmacokinet       Date:  1978 Mar-Apr       Impact factor: 6.447

2.  Binding of digitoxin, digoxin and gitoxin to human serum albumin.

Authors:  J P Tillement; R Zini; M Lecomte; P d'Athis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1980       Impact factor: 2.441

3.  The effects of chronic renal insufficiency on the pharmacokinetics of doxycycline in man.

Authors:  G Houin; F Brunner; T Nebout; M Cherfaoui; G Lagrue; J P Tillement
Journal:  Br J Clin Pharmacol       Date:  1983-09       Impact factor: 4.335
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.